Hosted on MSN2mon
AI is revolutionizing the treatment of glaucoma - the world's second leading cause of blindness
Targeting RIPK3 could provide a novel approach to preserving RGCs and preventing further damage. Advances in artificial intelligence (AI) are paving the way for breakthroughs in identifying ...
Hosted on MSN2mon
AI aids in discovery of potential glaucoma drug candidates
Receptor-interacting protein kinase 3 (RIPK3), a key signaling molecule, is known to play a critical role in necroptosis, making it a promising target for therapeutic intervention. To identify ...